A coumaric acid analogue with a monoterpene moiety named floraosmanol A (1) was isolated from the flowers of Osmanthus fragrans var. aurantiacus. The chemical structure was elucidated on the basis of chemical and physicochemical evidence. Floraosmanol A (1) significantly inhibited nitric oxide (NO) production in lipopolysaccharide-(LPS) activated RAW264.7 macrophages and the release of -hexosaminidase as a marker of degranulation from rat basophile leukemia (RBL-2H3) cells. In addition, several cinnamic acid analogues were conjugated with geraniol and 3-methyl-2-buten-1-ol through an ester linkage. The inhibitory effects on NO production and the release of -hexosaminidase of the synthesized compounds were examined for structure-activity relationships.
The inorganic free radical NO acts an essential multifunctional mediator in various biological systems. However, the excessive production of NO by inducible NOS (iNOS) has been implicated in physiologic and pathologic processes such as chronic and acute inflammation. Therefore, the development of NO production inhibitors has potential because of their therapeutic effects against various types of inflammation. We recently reported the isolation and structure elucidation of megastigmane glycosides and decalactone from the flowers of Osmanthus fragrans var. aurantiacus, as well as the weak inhibitory effects on NO production of several constituents such as lignans in LPS-activated RAW264.7 macrophages [1] . On the other hand, we have investigated several anti-allergic constituents from natural medicines. We recently reported various inhibitors including diarylheptanoids and acylated oleanane-type triterpene saponins on the release of -hexosaminidase, which is stored in the secretory granules of mast cells and is released concomitantly with histamine when mast cells are immunologically activated [2, 3] .
In the present study, a new coumaric acid analogue with a monoterpene moiety, named floraosmanol A (1), was isolated from the flowers of O. fragrans var. aurantiacus. In the course of our studies on anti-inflammatory compounds from natural medicines [4] , the inhibitory effects of 1 on NO production in LPS-activated RAW264.7 macrophages and on the release of -hexosaminidase as a marker of degranulation from RBL-2H3 cells were investigated. Furthermore, several cinnamic acid analogues were conjugated with geraniol and 3-methyl-2-buten-1-ol through an ester linkage. The inhibitory effects on NO production and on the release of -hexosaminidase of the synthesized cinnamic acid analogues were examined for structure-activity relationship study. Here, we describe the isolation and structure elucidation of a new constituent, floraosmanol A (1), from the flowers of O. fragrans var. aurantiacus and the inhibitory effects of the constituents and related compounds on NO production and the release of -hexosaminidase.
The MeOH extract (43.8% from the dried flowers of O. fragrans var. aurantiacus) was partitioned into a n-hexane-H 2 O (1:1, v/v) mixture to give n-hexane-soluble (4.6%) and aqueous fractions. The aqueous phase was further extracted with CHCl 3 to give CHCl 3 -(2.8%) and H 2 O-(36.4%) soluble fractions, as described previously [1] . The CHCl 3 -soluble fraction was subjected to normal-phase and reversed-phase silica gel column chromatography and repeated HPLC to give floraosmanol A (1, 0.0015%) and (2E,6R)-(-)-2,6dimethyl-2,7-octadiene-1,6-diol (2, 0.010%) [5] (Figure 1 ). As shown in Figure 2 , DQF COSY experiments indicated the presence of partial structures (written in bold), and HMBC experiments yielded long-range correlations between the following protons and carbons: H 2 -1 and C-3, 10, 9'; H-3 and C-1, 4, 5, 10; H 2 -4 and C-2, 3; H 2 -5 and C-3, 9; H-7 and C-6, 9; H 2 -8 and C-6; H 3 -9 and C-5, 6, 7; H 3 -10 and C-1, 2, 3; H-2',6' and C-4', 7'; H-3',5' and C-1'; H-7' and C-2', 9'; H-8' and C-1', 9'. These results supported the structure of 1 as a coumaric acid derivative with a 2,6-dimethyl-2,7-octadiene-1,6-diol moiety.
Finally, 1 was derived by esterification with the known monoterpene, (2E,6R)-(-)-2,6-dimethyl-2,7-octadiene-1,6-diol (2). Namely, 2 was conjugated with 3, which was obtained from a coumaric acid protected by tert-butyldimethylsilyl (TBS) group, by using EDCI in the presence of DMAP to give 4. Finally, 1 was provided from 4 by the deprotection of the TBS group. On the basis of these findings, the absolute configuration of the 6-position and the geometry of the 2-position in floraosmanol A (1) was clarified to be R and E, respectively, and the structure of 1 was determined as shown.
The inhibitory effects of the constituents (1 and 2) on NO production in LPS-activated RAW264.7 macrophages were examined. Floraosmanol A (1) displayed an inhibitory effect Next, several cinnamic acid analogues were synthesized for a structure-activity relationship study. Namely, 3-methyl-2-buten-1-ol was subjected to condensation with acids [cinnamic acid (13), coumaric acid analogue (3), and caffeic acid analogue (14)], which were either commercial samples or compounds obtained from commercial samples by protection of one or two hydroxy moieties with TBS groups, to provide the conjugates 5, 15, and 17. The protecting groups of 15 and 17 were removed to afford 6 and 7, respectively. Furthermore, methylation of 7 produced the corresponding 8. In the same way, conjugates 9−12 were prepared from geraniol with 3, 13, or 14, respectively. All synthesized compounds were evaluated for their inhibitory effects on NO production. Compounds 6, 7, 10, and 11 significantly inhibited NO production [inhibition (%): 25.5 ± 2.7 (for 6), 84.8 ± 1.1 (for 7), 58.6 ± 2.3 (for 10), and 99.7 ± 0.4 (for 11), at 30 M, respectively]. The effects of compounds 7 and 11 are also consistent with the previous report by Uwai et al. [6] . On the other hand, the NO inhibitory effects of compounds with the geranyl[(E)-3,7- dimethyl-2,6-octadien-1-yl] group (10 and 11) were stronger than those of compounds with a 3-methyl-2-buten-1-yl group (6 and 7). The findings indicate that 1) the geranyl group is more important than the 3-methyl-2-buten-1-yl group 2) the caffeoyl moiety and coumaroyl moiety are essential to induce the inhibitory effect 3) the caffeoyl group is more important than the coumaroyl group 4) cinnamoyl and (3,4-dimethoxy)cinnamoyl groups reduced the effect.
Next, all synthesized compounds were evaluated for their inhibitory effects on -hexosaminidase release. Compounds 7, 9, and 12 displayed more potency for inhibiting the release of hexosaminidase than a reference compound, ketotifen [inhibition: 44.2% (P<0.01) at 100 M] [2] . Particularly, 3-methyl-2-buten-1-yl trans-4-caffeate (7) substantially showed the inhibitory effect [inhibition: 28.9% at 10 M, 39.1% at 30 M]. 
Experimental
General: The following instruments were used to obtain physical data: specific rotations, a Horiba SEPA-300 digital polarimeter (l = 5 cm); IR spectra, a Thermo Electron Nexus 470; EIMS and HREIMS, JEOL JMS-GCMATE mass spectrometer; 1 H NMR spectra, JEOL JNM-ECS400 (400 MHz), JEOL JNM-LA500 (500 MHz), and JEOL JNM-ECA600 (600 MHz) spectrometers; 13 C NMR spectra, JEOL JNM-ECS400 (100 MHz), JEOL JNM-LA500 (125 MHz), and JEOL JNM-ECA600 (150 MHz) spectrometers with tetramethylsilane as an internal standard; HPLC, a Shimadzu RID-6A refractive index and SPD-10Avp UV-VIS detectors. COSMOSIL 5C18-MS-II (250 × 4.6 mm i.d. and 250 × 20 mm i.d.) columns were used for analytical and preparative purposes. 
Extraction and isolation:
The flowers (2.0 kg) of O. fragrans var. aurantiacus were extracted 3 times with methanol under reflux for 3 h. Evaporation of the solvent under reduced pressure provided a methanol extract (874.9 g, 43.8%). Part of this (824.7 g) was partitioned into a n-hexane-H 2 O (1:1, v/v) mixture to furnish a n-hexane-soluble fraction (85.7 g, 4.6%) and an aqueous phase. The aqueous phase was further extracted with CHCl 3 to give a CHCl 3soluble fraction (53.3 g, 2.8%) and a H 2 O-soluble fraction (685.4 g, 37.6%), as described previously [1] . The CHCl 3 -soluble fraction (48.25 g) was subjected to normal phase silica gel CC [700 g, n-hexane → n-hexane:EtOAc 
Synthesis of floraosmanol A (1):
A solution of a coumaric acid derivative (3, 42 mg, 0.15 mmol), obtained from coumaric acid and TBSCl, in CH 2 Cl 2 (4.0 mL) was treated with (2E,6R)-(-)-2,6dimethyl-2,7-octadiene-1,6-diol (2, 25 mg, 0.15 mmol) in the presence of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCl, 43 mg, 0.22 mmol) and N,N-dimethylaminopyridine (DMAP, 1.8 mg, 0.015 mmol) and the solution was stirred under N 2 at room temperature for 12 h. The solvent was removed under reduced pressure and the residue was poured into water and the whole was extracted with CHCl 3 . The CHCl 3 extract was washed with brine and water. Removal of the solvent under reduced pressure furnished a residue, which was purified by normal-phase silica gel CC [n-hexane-EtOAc (10:1 → 2:1, v/v)] to give 4 (33 mg, 52%). A solution of 4 (25 mg, 0.057 mmol) in anhydrous THF (1.0 mL) was treated with tetrabutylammonium fluoride (TBAF, 0.23 mL, ca. 1mol/L in THF) and the solution was stirred under N 2 at 0°C for 30 min. The reaction mixture was poured into water and the whole was extracted with EtOAc. The EtOAc extract was washed with brine and water. Removal of the solvent under reduced pressure furnished a residue, which was purified by normal-phase silica gel CC [n-hexane-EtOAc (2:1, v/v)] to give 1 (12 mg, 64%). (7) 
3-Methyl-2-buten-1-yl trans-4-caffeate

Synthesis of compounds 8 and 12 by methylation:
A solution of caffeic acid analogue (11, 22 mg, 0.071 mmol)] in DMF (1.0 mL) was treated with sodium hydride (60%, dispersion in paraffin liquid, 17 mg, 0.43 mmol), and the mixture was stirred for 15 min at 0°C. Methyl iodide (CH 3 I, 0.044 mL, 0.71 mmol) was added to the solution and the mixture was stirred under N 2 at room temperature for 2 h. The reaction mixture was quenched with ice-water and extracted 4 times with EtOAc. The combined organic layers was successively washed with saturated aqueous NaHCO 3 and brine, then dried over Na 2 SO 4 powder and the filtrate, under reduced pressure, furnished a residue, which was purified by silica gel CC [n-hexane-EtOAc (2:1, v/v)] to give 12 (17.4 mg, 71%). Compound 8 was obtained from 7 according to the same procedure. (8) Colorless oil Rf: 0.40 (n-hexane:EtOAc, 2:1). IR (film): 2950, 1717, 1638, 1509, 1458, 1165 cm -1 . 1 
3-Methyl-2-buten-1-yl trans-4-(3',4'-dimethoxy)cinnamate
Effects on production of NO in LPS-stimulated RAW264.7 macrophages:
The total amount of nitrite in a medium is used as an indicator of NO synthesis. The screening test for NO production using murine macrophage cells, RAW264.7 cells [ATCC No. TIB-71, obtained from Dainippon Pharmaceutical (Osaka, Japan)] was described previously [10] . Briefly, RAW264.7 cells were cultured in DMEM, and the suspension seeded into a 96-well microplate at 2.5×10 5 cells/100 L/well. After 6 h, non-adherent cells were removed by washing with PBS, the adherent cells were cultured in 100 µL of fresh medium containing the test compounds for 10 min, and then 100 L of the medium containing LPS (from E. coli, 055: B5, Sigma) was added to stimulate the cells for 18 h (final concentration of LPS, 10 µg/mL). The nitrite concentration was measured from the supernatant by a Griess reaction. NO production in each well was assessed by measuring the accumulation of nitrite in the culture medium using Griess reagent. Inhibition (%) was calculated using the following formula and the IC 50 was determined graphically (n=4).
Inhibition (%) = [(A-B)/(A-C)]×100
A-C: Nitrite concentration (g/mL) A: LPS (+), Sample (-); B: LPS (+), Sample (+); C: LPS (-), Sample (-)
Effects on the release of -hexosaminidase from RBL-2H3 cells:
The inhibitory effects of the test samples on the release of -hexosaminidase from RBL-2H3 cells [JCRB0023, obtained from Health Science Research Resources Bank (Osaka, Japan)] were evaluated by a method reported previously, with some modifications [11] .
Briefly, RBL-2H3 cells were dispensed into 48-well plates at a concentration of 4  10 4 cells/well using Eagle's minimum essential medium (MEM, Sigma) containing fetal calf serum (10%), penicillin (100 units/mL), streptomycin (100 g/mL), and 0.45 g/mL of anti-DNP IgE, and these were incubated overnight at 37°C in 5% CO 2 for sensitization of the cells. Then the cells were washed twice with 200 l of Siraganian buffer [119 mM NaCl, 5 mM KCl, 0.4 mM MgCl 2 , 25 mM piperazine-N,N'-bis(2ethanesulfonic acid) (PIPES), and 40 mM NaOH, pH 7.2], and incubated in 80 L of Siraganian buffer [5.6 mM glucose, 1 mM CaCl 2 , and 0.1% bovine serum albumin (BSA) were added] for an additional 10 min at 37°C. Aliquots (10 L) of test sample solution were added to each well and incubated for 10 min, followed by the addition of 10 L of antigen (DNP-BSA; final concentration 10 g/mL) at 37°C for 10 min to stimulate the cells to evoke allergic reactions (degranulation). The reaction was stopped by cooling in an ice bath for 10 min. The supernatant (40 L) was transferred into a 96-well microplate and incubated with 40 L of substrate ( Under these conditions, it was calculated that 10-15% of -hexosaminidase was released from the cells in the control groups by determination of the total -hexosaminidase activity after treatment with 0.05% Triton X-100. In order to clarify that the antiallergic effects of samples were due to the inhibition of hexosaminidase release, but not the false positive by the inhibition of -hexosaminidase activity, the following assay was carried out. The supernatant (36 L) of the control group as an enzyme solution, the substrate solution (40 L), and test sample solution (4 L) were transferred into a 96-well microplate and enzyme activity was examined as described above.
Statistics:
Values were expressed as means±S.E.M. One-way analysis of variance following Dunnett's test was used for statistical analysis. Probability (P) values less than 0.05 were considered significant.
